Joshua Z. Goldenberg, ND, answered our questions about his team’s study aimed to assess the efficacy and safety of biofeedback-based interventions for treating irritable bowel syndrome among adults and...
In this video, Dr Horst, from Vanderbilt University Medical Center, discusses current treatment challenges in the management of inflammatory bowel disease (IBD), the importance of choosing the right...
In this podcast, Alexander Rothman, PhD, discusses his team's latest analysis of CANTOS, which evaluated whether interleukin-1β inhibition would reduce blood pressure, prevent incident...
A study team recently examined the risk of ischemic strokes and transient ischemic attacks among patients who discontinued vitamin K antagonist therapy. We spoke with lead authors Carlos Martinez, MD, MSc,...
A new analysis of the ArthritisPower registry aimed to identify factors that patients believe influenced their physician’s treatment decisions. Lead authors W. Benjamin Nowell, PhD, and Kelly Gavigan, MPH,...
Atul Deodhar, MD, MRCP, from Oregon Health and Science University, answers our questions about the findings from the DISCOVER-1 clinical trial on the efficacy of guselkumab for the treatment of patients...
He discusses his research on cenobamate as adjunctive therapy for adults with uncontrolled focal seizures, how the results of this research aided in cenobamate's approval by the Food and Drug...
Diego J. Maselli, MD, answers our questions about choosing the right biologic for patients with severe asthma, the costs of biologics, and challenges to patient adherence to these therapies.
To determine the safety and impact of TLD on respiratory adverse events among patients with chronic obstructive pulmonary disease, a research team conducted a multicenter trial involving 82 patients....
